Our study shows that Robinin, as an inhibitor of TLR2, significantly inhibits the proliferation and migration of pancreatic cancer cells, which is reversed by the combination of CU-T12-9 and Robinin. The gene discussed is TLR2; the disease is familial pancreatic carcinoma.